Page results
-
A national study with initial results shows steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients.
-
The Sickle Cell Society (SCS) and the UK Thalassaemia Society (UKTS) have worked in partnership with the NHS sickle cell and thalassaemia (SCT) screening programme to engage with communities less likely to access health information through usual NHS channels. The societies provide feedback from people that share the same population background or have experience of the condition and to feed into the programme updates and improvements.
-
As an organisation, UCLH needs to minimise the environmental impact of our buildings and the energy they use and maximise our use of any technology available to support these changes. This page outlines our progress to date.
-
On Sunday 23 November, the Royal National Orthopaedic Hospital (RNOH) successfully connected to UCLH’s Epic electronic health record (EHR). This is another milestone in our collaboration and digital transformation across North Central London.
-
Education and training videos for Red Cell Network patients
-
This page has been written for patients who are having radioactive iodine (131I) ablation and/or radioiodine treatment for thyroid cancer.
-
Patient information for Red Cell Network patients
-
Medtronic are discontinuing the MiniMed™ Mio™ Infusion sets. If you are currently using MiniMed™ Mio™ infusion sets, you will need to change to an alternative infusion set before 31 March 2023. After this date, MiniMed™ Mio™ infusion sets will no longer be available.
-
UCLH has welcomed its 1000th patient to our proton beam therapy department, which opened in December 2021.
-
UCLH Charity is delighted to announce that the Dangoor Family’s Exilarch’s Foundation has pledged a £1.2m gift to support the next phase of the development of the CAR T programme at University College London Hospitals NHS Foundation Trust (UCLH). The CAR T Speed Release Project aims to reduce the time between extracting patient’s stem cells and injecting re-engineered CAR T cells back into patients with cancer to fight cancer cells.
File results
-
FOI/2021/0529 - Radiology department e-mail system for patients to reschedule appointments
-
FOI/2021/0531 - Neonatal care unit complaints over limited access due to Covid-19 restrictions
-
FOI/2021/0536 - PAT Testing
-
FOI/2021/0537 - Clinical waste information
-
FOI/2021/0538 - Treatment for triple-negative breast cancer
-
FOI/2021/0544 - Deaths for vaccinated and unvaccinated Covid-19 patients
-
FOI/2021/0547 - Stranded patients 13 days or more
-
FOI/2021/0550 - IT organisation chart and banding
-
FOI/2021/0551 - Analysing the treatment of neurology patients
-
FOI/2021/0553 - Clinical research organisations performing clinical trials